ALETTA Registration
ALETTA 2.0
Be the First to Access ALETTA 2.0 – Launching August 2023! Follow us on LinkedIn to join the initial group of private users.
ALETTA 1.0 assists patients in determining their optimal dose through the titration method and assesses the impact of cannabinoid treatments on Quality of Life without being restricted to a specific disease. Meanwhile, ALETTA 2.0 is an advanced Real-World Evidence tool that enables disease-specific studies and Patient Reporting Outcomes. It allows for patient treatment monitoring and the execution of sophisticated studies in both real-world and controlled settings.